Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Inthepezon Sep 30, 2021 10:05am
75 Views
Post# 33943026

RE:RE:RE:Proof.

RE:RE:RE:Proof.You sound very bullish here lmao.

I told you guys I was bearish when this stock was in the $1.40-$1.55 range. You guys mocked me, but I was right. The stock is now $1.16 and only recently have I turned bullish on it. If you had just listened to me, you would have saved a ton of money over the last week alone and you could have bought back right here.

No one wants to see your daddy’s car. Post your shares. Lmao 


Rarbar99 wrote:

This isn't a good investment and the company itself is unpromising. So 25K is all you will get from me. I was willing to add 10K more but Pez didn't want to take a screenshot of his average price, gee I wonder why..

 

EfTOates28 wrote:
brah you have 25k shares and talking like your a baller brah I'm down 37k step your game up

 

 



<< Previous
Bullboard Posts
Next >>